{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:46:28Z","timestamp":1775706388859,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2012\/738"],"award-info":[{"award-number":["2012\/738"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Cancer Foundation Uppsala","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5943-3","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T13:03:03Z","timestamp":1564405383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-5409","authenticated-orcid":false,"given":"Dijana","family":"Djureinovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Landelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Al Sayegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Kamali-Moghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Micke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"St\u00e5hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"1","key":"5943_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5943_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.201410-1777CI","volume":"191","author":"LT Tanoue","year":"2015","unstructured":"Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191(1):19\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5943_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"key":"5943_CR4","doi-asserted-by":"publisher","first-page":"j5742","DOI":"10.1136\/bmj.j5742","volume":"359","author":"DR Baldwin","year":"2017","unstructured":"Baldwin DR, Ten Haaf K, Rawlinson J, Callister MEJ. Low dose CT screening for lung cancer. BMJ. 2017;359:j5742.","journal-title":"BMJ"},{"issue":"11","key":"5943_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jech-2014-204079","volume":"69","author":"K Ten Haaf","year":"2015","unstructured":"Ten Haaf K, de Koning HJ. Overdiagnosis in lung cancer screening: why modelling is essential. J Epidemiol Community Health. 2015;69(11):1035\u20139.","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"5943_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.prnil.2016.09.002","volume":"4","author":"S Cabarkapa","year":"2016","unstructured":"Cabarkapa S, Perera M, McGrath S, Lawrentschuk N. Prostate cancer screening with prostate-specific antigen: a guide to the guidelines. Prostate Int. 2016;4(4):125\u20139.","journal-title":"Prostate Int"},{"key":"5943_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-015-0296-5","volume":"13","author":"EH Kim","year":"2015","unstructured":"Kim EH, Andriole GL. Prostate-specific antigen-based screening: controversy and guidelines. BMC Med. 2015;13:61.","journal-title":"BMC Med"},{"issue":"8","key":"5943_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/14737159.2016.1194758","volume":"16","author":"M Szajnik","year":"2016","unstructured":"Szajnik M, Czystowska-Kuzmicz M, Elishaev E, Whiteside TL. Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. Expert Rev Mol Diagn. 2016;16(8):811\u201326.","journal-title":"Expert Rev Mol Diagn"},{"issue":"11","key":"5943_CR9","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1158\/1078-0432.CCR-03-0787","volume":"10","author":"GJ Rustin","year":"2004","unstructured":"Rustin GJ, Bast RC Jr, Kelloff GJ, Barrett JC, Carter SK, Nisen PD, Sigman CC, Parkinson DR, Ruddon RW. Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res. 2004;10(11):3919\u201326.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"5943_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1200\/JCO.2013.50.4357","volume":"32","author":"G Sozzi","year":"2014","unstructured":"Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol. 2014;32(8):768\u201373.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5943_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2013.10.008","volume":"83","author":"JR Jett","year":"2014","unstructured":"Jett JR, Peek LJ, Fredericks L, Jewell W, Pingleton WW, Robertson JF. Audit of the autoantibody test, EarlyCDT(R)-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer. 2014;83(1):51\u20135.","journal-title":"Lung Cancer"},{"issue":"6378","key":"5943_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926\u201330.","journal-title":"Science"},{"issue":"4","key":"5943_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/JTO.0b013e31824ab6b0","volume":"7","author":"WL Bigbee","year":"2012","unstructured":"Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol. 2012;7(4):698\u2013708.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"5943_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12885-018-4024-3","volume":"18","author":"GCW Chu","year":"2018","unstructured":"Chu GCW, Lazare K, Sullivan F. Serum and blood based biomarkers for lung cancer screening: a systematic review. BMC Cancer. 2018;18(1):181.","journal-title":"BMC Cancer"},{"issue":"7","key":"5943_CR15","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1164\/rccm.201708-1678ST","volume":"196","author":"PJ Mazzone","year":"2017","unstructured":"Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, et al. Evaluating molecular biomarkers for the early detection of lung Cancer: when is a biomarker ready for clinical use? An official American Thoracic Society policy statement. Am J Respir Crit Care Med. 2017;196(7):e15\u201329.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5943_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1158\/1055-9965.EPI-11-0932","volume":"21","author":"CV Pecot","year":"2012","unstructured":"Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, Jett JR, Putnam JB, Callaway-Lane C, Deppen S, et al. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomark Prev. 2012;21(5):786\u201392.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"5943_CR17","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192.","journal-title":"PLoS One"},{"issue":"15","key":"5943_CR18","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39(15):e102.","journal-title":"Nucleic Acids Res"},{"key":"5943_CR19","unstructured":"Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. New York: Taylor & Francis; 1984."},{"issue":"4","key":"5943_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/tpj.2010.56","volume":"10","author":"RM Parry","year":"2010","unstructured":"Parry RM, Jones W, Stokes TH, Phan JH, Moffitt RA, Fang H, Shi L, Oberthuer A, Fischer M, Tong W, et al. K-nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J. 2010;10(4):292\u2013309.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"5943_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1109\/TCYB.2014.2331284","volume":"45","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Fang J, Wang Q. Online anomaly detection in crowd scenes via structure analysis. IEEE Trans Cybern. 2015;45(3):562\u201375.","journal-title":"IEEE Trans Cybern"},{"key":"5943_CR22","unstructured":"Balakrishnama S, Ganapathiraju A. Linear discriminant analysis - a brief tutorial: Department of Electrical and Computer Engineering, Mississippi State University."},{"key":"5943_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1741-7015-9-133","volume":"9","author":"JD Warren","year":"2011","unstructured":"Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011;9:133.","journal-title":"BMC Med"},{"issue":"4","key":"5943_CR24","doi-asserted-by":"publisher","first-page":"e009555","DOI":"10.1161\/JAHA.118.009555","volume":"8","author":"E Bouwens","year":"2019","unstructured":"Bouwens E, Brankovic M, Mouthaan H, Baart S, Rizopoulos D, van Boven N, Caliskan K, Manintveld O, Germans T, van Ramshorst J, et al. Temporal patterns of 14 blood biomarker candidates of cardiac remodeling in relation to prognosis of patients with chronic heart failure-the bio- SH i FT study. J Am Heart Assoc. 2019;8(4):e009555.","journal-title":"J Am Heart Assoc"},{"key":"5943_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1465-9921-14-85","volume":"14","author":"E Klaile","year":"2013","unstructured":"Klaile E, Klassert TE, Scheffrahn I, Muller MM, Heinrich A, Heyl KA, Dienemann H, Grunewald C, Bals R, Singer BB, et al. Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons. Respir Res. 2013;14:85.","journal-title":"Respir Res"},{"issue":"2","key":"5943_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","volume":"57","author":"S Benchimol","year":"1989","unstructured":"Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989;57(2):327\u201334.","journal-title":"Cell"},{"issue":"9","key":"5943_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00595-017-1477-y","volume":"47","author":"H Nakamura","year":"2017","unstructured":"Nakamura H, Nishimura T. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer. Surg Today. 2017;47(9):1037\u201359.","journal-title":"Surg Today"},{"issue":"3","key":"5943_CR28","first-page":"148","volume":"10","author":"B Bagaria","year":"2013","unstructured":"Bagaria B, Sood S, Sharma R, Lalwani S. Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med. 2013;10(3):148\u201357.","journal-title":"Cancer Biol Med"},{"key":"5943_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2407-3-26","volume":"3","author":"A Figueredo","year":"2003","unstructured":"Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based C. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.","journal-title":"BMC Cancer"},{"issue":"5","key":"5943_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4149\/neo_2012_064","volume":"59","author":"X Li","year":"2012","unstructured":"Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M. Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma. 2012;59(5):500\u20137.","journal-title":"Neoplasma"},{"issue":"12","key":"5943_CR31","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.4049\/jimmunol.1102903","volume":"188","author":"AM Burkhardt","year":"2012","unstructured":"Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K, Barbosa-Quintana O, Valle-Rios R, Hevezi PA, Zuniga J, Selman M, et al. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol. 2012;188(12):6399\u2013406.","journal-title":"J Immunol"},{"issue":"3","key":"5943_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.bbrc.2017.09.113","volume":"493","author":"YJ Guo","year":"2017","unstructured":"Guo YJ, Zhou YJ, Yang XL, Shao ZM, Ou ZL. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer. Biochem Biophys Res Commun. 2017;493(3):1159\u201367.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"5943_CR33","doi-asserted-by":"publisher","first-page":"e44080","DOI":"10.1371\/journal.pone.0044080","volume":"7","author":"A Matsui","year":"2012","unstructured":"Matsui A, Yokoo H, Negishi Y, Endo-Takahashi Y, Chun NA, Kadouchi I, Suzuki R, Maruyama K, Aramaki Y, Semba K, et al. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4\/80- cells and promotes tumor progression. PLoS One. 2012;7(8):e44080.","journal-title":"PLoS One"},{"issue":"2","key":"5943_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.lungcan.2011.02.016","volume":"74","author":"E Jantus-Lewintre","year":"2011","unstructured":"Jantus-Lewintre E, Sanmartin E, Sirera R, Blasco A, Sanchez JJ, Taron M, Rosell R, Camps C. Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC. Lung Cancer. 2011;74(2):326\u201331.","journal-title":"Lung Cancer"},{"issue":"9","key":"5943_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3727\/000000007783980864","volume":"16","author":"W Naumnik","year":"2007","unstructured":"Naumnik W, Izycki T, Swidzinska E, Ossoliniska M, Chyczewska E. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Oncol Res. 2007;16(9):445\u201351.","journal-title":"Oncol Res"},{"issue":"1","key":"5943_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13014-018-1075-1","volume":"13","author":"K Reynders","year":"2018","unstructured":"Reynders K, Wauters E, Moisse M, Decaluwe H, De Leyn P, Peeters S, Lambrecht M, Nackaerts K, Dooms C, Janssens W, et al. RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue. Radiat Oncol. 2018;13(1):131.","journal-title":"Radiat Oncol"},{"issue":"7","key":"5943_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc2656","volume":"9","author":"J Baselga","year":"2009","unstructured":"Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer. 2009;9(7):463\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5943_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40259-016-0205-2","volume":"31","author":"N Karachaliou","year":"2017","unstructured":"Karachaliou N, Lazzari C, Verlicchi A, Sosa AE, Rosell R. HER3 as a therapeutic target in Cancer. BioDrugs. 2017;31(1):63\u201373.","journal-title":"BioDrugs"},{"key":"5943_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.compbiolchem.2013.04.007","volume":"47","author":"AE Hassanien","year":"2013","unstructured":"Hassanien AE, Al-Shammari ET, Ghali NI. Computational intelligence techniques in bioinformatics. Comput Biol Chem. 2013;47:37\u201347.","journal-title":"Comput Biol Chem"},{"issue":"207","key":"5943_CR40","doi-asserted-by":"publisher","first-page":"207ra142","DOI":"10.1126\/scitranslmed.3007013","volume":"5","author":"XJ Li","year":"2013","unstructured":"Li XJ, Hayward C, Fong PY, Dominguez M, Hunsucker SW, Lee LW, McLean M, Law S, Butler H, Schirm M, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med. 2013;5(207):207ra142.","journal-title":"Sci Transl Med"},{"issue":"9","key":"5943_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/07357907.2017.1373120","volume":"35","author":"JR Hocker","year":"2017","unstructured":"Hocker JR, Deb SJ, Li M, Lerner MR, Lightfoot SA, Quillet AA, Hanas RJ, Reinersman M, Thompson JL, Vu NT, et al. Serum monitoring and phenotype identification of stage I non-small cell lung Cancer patients. Cancer Investig. 2017;35(9):573\u201385.","journal-title":"Cancer Investig"},{"key":"5943_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2407-5-83","volume":"5","author":"SY Yang","year":"2005","unstructured":"Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer. 2005;5:83.","journal-title":"BMC Cancer"},{"key":"5943_CR43","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/1471-2407-10-690","volume":"10","author":"J Maeda","year":"2010","unstructured":"Maeda J, Higashiyama M, Imaizumi A, Nakayama T, Yamamoto H, Daimon T, Yamakado M, Imamura F, Kodama K. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer. 2010;10:690.","journal-title":"BMC Cancer"},{"issue":"4","key":"5943_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.M500006-MCP200","volume":"4","author":"TD Veenstra","year":"2005","unstructured":"Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics. 2005;4(4):409\u201318.","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"5943_CR45","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/pr300776t","volume":"12","author":"NJ Bond","year":"2013","unstructured":"Bond NJ, Shliaha PV, Lilley KS, Gatto L. Improving qualitative and quantitative performance for MS(E)-based label-free proteomics. J Proteome Res. 2013;12(6):2340\u201353.","journal-title":"J Proteome Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5943-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:12:56Z","timestamp":1595891576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5943-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5943"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5943-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Swedish Biobank Legislation and was approved by the Uppsala University Ethical Review Board (2014\/501). The need for informed consent was waived by the aforementioned authorities due to that a sizeable portion of the patients were already deceased. Individual patient data has not been made available and the dataset has been handled anonymized.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}